Pratteln, Switzerland, April 16, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the latest progress on the commercial rollout of AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD).

Back in 2017, the FDIC accused Bank of America of refusing to pay over $500 million in assessments — a figure it later ...

IPAX-Linz is a single-arm Phase 2 investigator-initiated trial (IIT). IPAX-Linz evaluates the safety, tolerability and preliminary efficacy of TLX101 therapy, in combination with external beam ...

Explore the latest changes in drug pricing as Trump aims to revamp Medicare negotiations for prescription drugs.

TOKYO (AP) — Japanese regulators on Tuesday accused U.S. tech giant Google of violating anti-monopoly laws, echoing similar moves in the U.S. and Europe. Google Japan said in a statement that it found ...

Corbus Pharmaceuticals Holdings Inc. closed 90.32% below its 52-week high of $61.90, which the company reached on July 31st.

SPRINGFIELD, Mo., April 15, 2025 (GLOBE NEWSWIRE) -- Paul Mueller Company (OTC: MUEL) announces a $17.9 million, 20,000-square-foot expansion to its Components Products facility. This expansion ...

The stock's fall snapped a two-day winning streak.

POPULUS Health Technologies today announced that Edith Hodkinson has joined as Chief Strategy Officer. Edith brings over 25 years of experience in the healthcare industry leading digital innovation ...

The European Commission has granted the amyloid-beta monoclonal antibody Leqembi Marketing Authorization in the European Union. Lecanemab is ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and ...

Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year. The costs will be felt ...